title: Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.
abstract: Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure.
authors.affiliation: Pôle de Recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium. damien.gruson@uclouvain.be
authors.forename: Damien
authors.initials: D
authors.lastname: Gruson
authors.forename: Frédéric
authors.initials: F
authors.lastname: Thys
authors.forename: Franck
authors.initials: F
authors.lastname: Verschuren
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D004630:Emergencies; D005109:Extracellular Matrix / Q000378:metabolism; D006333:Heart Failure / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000473:pathology; D018377:Neurotransmitter Agents / Q000378:metabolism; D018384:Oxidative Stress; D011379:Prognosis
chemical_list: D015415:Biomarkers; D018377:Neurotransmitter Agents